WuXi Biologics (Cayman) Inc.
WXIBF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $8 | $10 | $6 | $9 |
| Short-Term Investments | $2 | $2 | $2 | $2 |
| Receivables | $6 | $6 | $5 | $3 |
| Inventory | $2 | $2 | $2 | $2 |
| Other Curr. Assets | $6 | $2 | $2 | $3 |
| Total Curr. Assets | $24 | $21 | $18 | $20 |
| Property Plant & Equip (Net) | $28 | $30 | $26 | $20 |
| Goodwill | $2 | $2 | $2 | $2 |
| Intangibles | $0 | $1 | $1 | $1 |
| Long-Term Investments | -$0 | $3 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3 | $0 | $2 | $2 |
| Total NC Assets | $33 | $35 | $31 | $25 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $57 | $57 | $50 | $44 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $1 | $1 |
| Short-Term Debt | $3 | $1 | $1 | $2 |
| Tax Payable | $1 | $1 | $1 | $1 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $5 | $5 | $6 | $5 |
| Total Curr. Liab. | $9 | $8 | $9 | $8 |
| LT Debt | $2 | $4 | $3 | $2 |
| Deferred Rev, NC | $0 | $1 | $1 | $1 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $3 | $5 | $4 | $3 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $2 | $2 | $2 |
| Total Liabilities | $11 | $13 | $13 | $11 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $1 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $16 | $13 | $12 | $7 |
| AOCI | $0 | $2 | $1 | $1 |
| Other Equity | $25 | $24 | $22 | $25 |
| Total Equity | $42 | $40 | $35 | $32 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $4 | $4 | $1 | $0 |
| Total Liab. & Tot. Equity | $57 | $57 | $50 | $44 |
| Net Debt | -$3 | -$5 | -$2 | -$5 |